Application 204959
- Type
- ANDA
- Sponsor
- QILU
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | No | No |
| 002 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | No | No |
| 003 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204959-001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | |
| A204959-002 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | |
| A204959-003 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204959-001 | AP |
| A204959-002 | AP |
| A204959-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204959-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204959-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204959-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2018-08-10 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A204959-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204959-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204959-003 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A204959-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204959-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204959-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204959-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204959-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204959-003 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A204959-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204959-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204959-003 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204959-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204959-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204959-003 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204959-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204959-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204959-003 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204959-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204959-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204959-003 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204959-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204959-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204959-003 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204959-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204959-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204959-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204959-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204959-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204959-003 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A204959-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204959-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204959-003 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204959-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204959-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204959-003 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204959-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204959-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204959-003 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204959-001 | AP | 1 | 1e350fbaab3a… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | BluePoint Laboratories | 1aba753c-d0c2-4b35-917a-9143dd4be468 | 2025-06-20 | Warnings, Adverse reactions | 204959 ANDA204959 68001-507 68001-506 68001-508 |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Apotex Corp. | 2c8f06a2-49b2-4169-94ef-182d13d248bf | 2025-05-21 | Warnings, Adverse reactions | 204959 ANDA204959 60505-6157 60505-6159 60505-6156 |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | 420196a5-f62d-473f-84d8-d7fc3f31c3d3 | 2024-10-17 | Warnings, Adverse reactions | 204959 ANDA204959 35369-0501 35369-0503 35369-0502 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 35369-0501 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Qilu Tianhe Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0501 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0501 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0501 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0501 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Qilu Tianhe Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0501 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0502 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Qilu Tianhe Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0502 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0502 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0502 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0502 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Qilu Tianhe Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0502 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0503 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Qilu Tianhe Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0503 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0503 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0503 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0503 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Qilu Tianhe Pharmaceutical Co., Ltd. | ANDA | Current |
| 35369-0503 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | ANDA | Current |
| 60505-6156 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6156 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6156 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6156 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6156 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6156 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6157 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6157 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6157 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6157 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6157 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6157 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6159 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6159 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6159 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6159 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6159 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 60505-6159 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | Apotex Corp. | ANDA | Current |
| 68001-506 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-506 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-506 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-506 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-507 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-507 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-507 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-507 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-508 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-508 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-508 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |
| 68001-508 | Piperacillin and Tazobactam | PIPERACILLIN and TAZOBACTAM | BluePoint Laboratories | ANDA | Current |